Humira is a human monoclonal antibody. It works by blocking tumor necrosis factor alpha (TNF-alpha), a cytokine that plays a ...

Adalimumab (brand name Humira) is an anti-TNF alpha agent that can be used for moderate-to-severe ulcerative colitis. While ...

Humira’s success is down to its incredible versatility – an anti-TNF drug, it is approved in a range of inflammatory diseases, including rheumatoid arthritis, plaque psoriasis and Crohn’s ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

The tumor necrosis factor inhibitors Enbrel (etanercept), Humira (adalimumab), Remicade (infliximab) and Cimzia (certolizumab pegol) are being investigated by the US Food and Drug Administration ...

AbbVie (NYSE:ABBV) has managed to keep its market share for its bestselling arthritis therapy, Humira, above 70%, generic drugmaker Samsung Bioepis said in a new report on Thursday as the ...

The oral drug is Celgene's offering in a crowded inflammation and immunology market, and part of a wave of new drugs looking to supercede the TNF inhibitors, led by AbbVie's Humira. NICE'S change ...